Thus, as in the current study, prior analyses of different patient populations have not supported a significant association between prediagnostic plasma levels of IGF-I or IGFBP-3 and the risk of pancreatic cancer. The gene discussed is IGFBP3; the disease is pancreatic neoplasm.